Alterations in erythrocyte membrane transporter expression levels in type 2 diabetic patients
Open Access
- 2 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 11 (1), 1-10
- https://doi.org/10.1038/s41598-021-82417-8
Abstract
Type 2 diabetes mellitus (T2DM) is one of the most common multifactorial diseases and several membrane transporters are involved in its development, complications and treatment. We have recently developed a flow-cytometry assay panel for the quantitative determination of red cell membrane protein levels with potential relevance in diseases. Here we report a detailed phenotypic analysis of a medium scale, clinically based study on the expression of T2DM-related membrane proteins, the GLUT1, GLUT3, MCT1, URAT1, ABCA1, ABCG2 and the PMCA4 transporters in erythrocytes. By comparing age-matched control subjects and three groups of T2DM patients (recently diagnosed, successfully managed, and patients with disease-related complications), we found significant differences in the membrane expression levels of the transporters in these groups. This is a first detailed analysis of T2DM related alterations in erythrocyte membrane transporter protein levels, and the results suggest significant changes in some of the transporter expression levels in various patient groups. By performing a further, more detailed analysis of the clinical and molecular biology parameters, these data may serve as a basis of establishing new, personalized diagnostic markers helping the prevention and treatment of type 2 diabetes.Funding Information
- Hungarian National Development and Innovation Office (NKFIH K-128011, VEKOP-2.1.1-15-2016-00117)
This publication has 32 references indexed in Scilit:
- Molecular Mechanisms of Cellular Cholesterol EffluxOnline Journal of Public Health Informatics, 2014
- Standards of Medical Care in Diabetes—2014Diabetes Care, 2013
- Calcium in Red Blood Cells—A Perilous BalanceInternational Journal of Molecular Sciences, 2013
- Expression Levels of the ABCG2 Multidrug Transporter in Human Erythrocytes Correspond to Pharmacologically Relevant Genetic VariationsPLOS ONE, 2012
- Urate Transporter Gene SLC22A12 Polymorphisms Associated with Obesity and Metabolic Syndrome in Caucasians with HypertensionKidney and Blood Pressure Research, 2012
- The Increased Protein Level of URAT1 was Observed in Obesity/Metabolic Syndrome Model MiceNucleosides, Nucleotides and Nucleic Acids, 2011
- Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatinPharmacogenomics, 2009
- Erythroid glucose transportersCurrent Opinion in Hematology, 2009
- Facilitative glucose transportersJBIC Journal of Biological Inorganic Chemistry, 1994
- The Effect of In Vivo Glucose Administration on Human Erythrocyte Ca2+-ATPase Activity and on Enzyme Responsiveness In Vitro to Thyroid Hormone and CalmodulinDiabetes, 1985